Brussels, 27/03/2015 (Agence Europe) - On Friday 27 March, the European Commission said that it has concluded that a German scheme exempting pharmaceutical companies from mandatory rebates was in line with EU State aid rules.
Germany introduced price freezes in the form of rebates to be granted by producers of certain prescription medicines of public sickness funds and private health insurers. The system allows derogations to be granted if a company can prove that the mandatory rebate...